EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES

EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES

Diğer sürümleri göster (1)

Aim. To compare the dynamics of intrarenal vascular resistance (IRVR), circadian blood pressure (BP) profile and glomerular filtration rate (GFR) in patients with arterial hypertension (HT) and type 2 diabetes mellitus (DM) who achieved the target BP levels (<130/80 mmHg) due to long-term com...

Detaylı Bibliyografya
Asıl Yazarlar:	O. A. Koshel'skaya, O. A. Zhuravleva
Materyal Türü:	Makale
Dil:	English
Baskı/Yayın Bilgisi:	Столичная издательская компания 2015-12-01
Seri Bilgileri:	Рациональная фармакотерапия в кардиологии
Konular:	intrarenal vascular resistance diabetes mellitus arterial hypertension target blood pressure combined antihypertensive treatment renin-angiotensin-aldosterone system inhibitors glomerular filtration rate
Online Erişim:	https://www.rpcardio.online/jour/article/view/464

Benzer Materyaller

Algorithm for differential administration of combination antihypertensive therapy in patients with Type 2 diabetes mellitus
Yazar:: O. A. Koshelskaya, ve diğerleri
Baskı/Yayın Bilgisi: (2013-08-01)

EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS
Yazar:: O. A. Koshel'skaya, ve diğerleri
Baskı/Yayın Bilgisi: (2015-12-01)

Markers of chronic kidney disease and disorders of renal hemodynamics in patients with medically-controlled arterial hypertension and high and very high cardiovascular risk
Yazar:: O. A. Koshel'skaya, ve diğerleri
Baskı/Yayın Bilgisi: (2018-11-01)

Arterial hypertension progression and changing activity of reninangiotensin-aldosterone and sympatho-adrenal systems
Yazar:: Sh. V. Akhadov, ve diğerleri
Baskı/Yayın Bilgisi: (2010-04-01)

Renin-angiotensin-aldosterone system in climacteric women with arterial hypertension. Antihypertensive therapy features
Yazar:: A. E. Bragina, ve diğerleri
Baskı/Yayın Bilgisi: (2005-12-01)

Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients
Yazar:: Annina S. Vischer, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Blood Pressure Control and Antihypertensive Treatment among Hemodialysis Patients—Retrospective Single Center Experience
Yazar:: Piotr Skonieczny, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES
Yazar:: O. A. Koshel'skaya, ve diğerleri
Baskı/Yayın Bilgisi: (2015-12-01)

Prospects of using genetic testing to increase the effectiveness of antihypertensive therapy
Yazar:: N. V. Drobotya, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

Efficacy of valsartan in the therapy of persistent microalbuminuria in normotensive patients with type 1 diabetes mellitus
Yazar:: Dragović Tamara, ve diğerleri
Baskı/Yayın Bilgisi: (2003-01-01)

THE CORRELATION BETWEEN THE RENIN AT ALDOSTERONE SYSTEM – ARTERIAL HYPERTENSION AND HORMONAL MECHANISMS
Yazar:: Liviu Stafie, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

Foe and friend in the COVID-19-associated acute kidney injury: an insight on intrarenal renin-angiotensin system
Yazar:: Xu Chuanming, ve diğerleri
Baskı/Yayın Bilgisi: (2021-12-01)

RAA System and Exercise Relationship
Yazar:: Sadettin Ünsal, ve diğerleri
Baskı/Yayın Bilgisi: (2019-09-01)

Significance of intrarenal vascular lesions in Ig A nephropathy prognosis
Yazar:: Hyeon Tae Yang, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
Yazar:: V. I. Podzolkov, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Role of antihypertensive medicines in prostate cancer: a systematic review
Yazar:: Chinonyerem O. Iheanacho, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Urinary angiotensinogen level is correlated with blood pressure level and proteinuria in patients with masked hypertension
Yazar:: Ozlem Tiryaki, ve diğerleri
Baskı/Yayın Bilgisi: (2018-10-01)

Blood aldosterone level in various types of atrial fibrillation
Yazar:: N. T. Vatutin, ve diğerleri
Baskı/Yayın Bilgisi: (2016-02-01)

Nocturnal diastolic blood pressure decline is associated with higher 25-hydroxyvitamin D level and standing plasma renin activity in a hypertensive population
Yazar:: Mingchen Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2017-11-01)

Role of renin–angiotensin aldosterone system on short-term blood pressure variability in hypertensive patients
Yazar:: Minako Inoue, ve diğerleri
Baskı/Yayın Bilgisi: (2018-10-01)

LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
Yazar:: Shuichi Ichikawa, ve diğerleri
Baskı/Yayın Bilgisi: (2011-06-01)

Research progress on the mechanism of food-derived antihypertensive peptides
Yazar:: WANG Baobei, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Antihypertensive Treatment Patterns in CKD Stages 3 and 4: The CKD-REIN Cohort Study
Yazar:: Margaux Costes-Albrespic, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Low plasma renin activity is associated with “Apparently” idiopathic atrial fibrillation
Yazar:: Youmei Shen, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING
Yazar:: V. S. Pykhtina, ve diğerleri
Baskı/Yayın Bilgisi: (2015-09-01)

INFLUENCE OF COMORBIDITIES ON BLOOD ALDOSTERONE LEVEL IN CHRONIC HEART FAILURE WITH PRESERVED SYSTOLIC FUNCTION OF THE LEFT VENTRICLE
Yazar:: N. T. Vatutin, ve diğerleri
Baskı/Yayın Bilgisi: (2017-12-01)

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes mellitus: the role of renin-angiotensin-aldosterone system (literature review) (part 1)
Yazar:: K. V. Skobeleva, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes: the role of renin-angiotensin-aldosterone system (literature review) (part 2)
Yazar:: K. V. Skobeleva, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

A New Perspective on the Renin-Angiotensin System
Yazar:: Adrian Martyniak, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

A traditional Korean fermented food, Gochujang exerts anti-hypertensive effects, regardless of its high salt content by regulating renin-angiotensin-aldosterone system in SD rats
Yazar:: Jung Eun Park, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

Strategies to improve blood pressure control and cardiovascular outcomes in hypertensive patients
Yazar:: E. van der Merwe, ve diğerleri
Baskı/Yayın Bilgisi: (2011-11-01)

Genetic polymorphism of renin-angiotensin-aldosterone system in type 2 diabetes and in combination with arterial hypertension among Dagestan inhabitants
Yazar:: Marat Z. Saidov, ve diğerleri
Baskı/Yayın Bilgisi: (2019-12-01)

Indicators of humoral regulation of the circulatory system in obese patients
Yazar:: Tatyana S. Zaletova, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

RAAS in diabetic retinopathy: mechanisms and therapies
Yazar:: Xin Li, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Combined antihypertensive medications
Yazar:: L. L. Kirichenko, ve diğerleri
Baskı/Yayın Bilgisi: (2007-12-01)

Soluble urinary somatic angiotensin converting enzyme is overexpressed in patients with preeclampsia: a potential new marker for the disease?
Yazar:: Fernando Sontag, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Fructose‐induced salt‐sensitive blood pressure differentially affects sympathetically mediated aortic stiffness in male and female Sprague‐Dawley rats
Yazar:: Dragana Komnenov, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Advances in Unraveling the Role of the Renin-Angiotensin-AldosteroneSystem in Osteoporosis Pathogenesis
Yazar:: Zige Liu, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Pharmacogenetic aspects of eprosartan therapy and polymorphic markers of renin-angiotensin-aldosterone system genes in Uzbek patients with essential arterial hypertension
Yazar:: D. R. Kurbanova, ve diğerleri
Baskı/Yayın Bilgisi: (2009-06-01)

Is the prognosis of non‐hypertensive, COVID‐19 patients treated with renin–angiotensin–aldosterone system inhibitors more uncertain?
Yazar:: Juan José García Martínez, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)